retatrutide type 2 diabetes phase 2 trial hba1c Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Lilly's Retatrutide shows promise in
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3






















:max_bytes(150000):strip_icc()/parentsglp1drugs-2d3907051543477aa74702d824c3b8eb.png)
